510(k) K030102
K030102 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3". The FDA issued a decision of Substantially Equivalent on Jan 24, 2003. The device falls under product code JJT (Enzyme Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Bayer Healthcare, LLC has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 24, 2003
- Date Received
- Jan 10, 2003
- Clearance Type
- Abbreviated
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Controls (Assayed And Unassayed)
- Device Class
- Class I
- Regulation Number
- 862.1660
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Bayer Healthcare, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.